Premier Pharmacy Labs Recalls Lidocaine and Phenylephrine Injection Vials
Premier Pharmacy Labs is recalling 323 vials of Lidocaine 0.5%/Phenylephrine 0.75% Injection due to a lack of sterility assurance identified during an FDA inspection.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of sterility assurance, which poses a significant risk of infection or serious injury, meeting the criteria for a Severe rating.
Plain-English summary
Premier Pharmacy Labs Inc is recalling 323 vials of Lidocaine 0.5%/Phenylephrine 0.75% P.F. INJ, 1mL Sterile SDV. The product is prescription-only and was distributed nationwide in the USA. The recall covers all lots remaining within their expiry dates.
The recall was initiated because an FDA inspection found insufficient environmental controls, potential cross-contamination, and a lack of product-specific process validations. These issues can result in a lack of sterility assurance for the product.
Consumers and healthcare providers should stop using the recalled product and contact their healthcare provider or the recalling firm for further instructions.
The recalled product
- Product
- Lidocaine 0.5%/Phenylephrine 0.75% P.F. INJ, 1mL Sterile SDV, Rx only, Premier Pharmacy Labs, 8265 Commercial Way, Weeki Wachee, FL 34613, NDC: 69623-176-31, barcode 6 69623 17631 0.
- Manufacturer
- Premier Pharmacy Labs Inc
- Category
- Drug — Injection
- Affected units
- 323
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots remaining within expiry.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 18 recalled by Premier Pharmacy Labs Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 18 products in this recall →Related recalls
Same manufacturer · Premier Pharmacy Labs Inc
See all →- SeverePremier Pharmacy Labs Recalls Isoproterenol HCL Bags Due to Sterility Concerns
FDA (Drugs) · 2019-07-03
- SeverePremier Pharmacy Labs Recalls Succinylcholine Chloride Syringes for Sterility Concerns
FDA (Drugs) · 2019-07-03
- SeverePremier Pharmacy Labs Recalls Phenylephrine Injection Due to Sterility Concerns
FDA (Drugs) · 2019-07-03
- SeverePremier Pharmacy Labs Recalls Droperidol Syringes Due to Sterility Concerns
FDA (Drugs) · 2019-07-03
- SeverePremier Pharmacy Labs Recalls Orphenadrine Citrate Syringes Due to Sterility Concerns
FDA (Drugs) · 2019-07-03
Same hazard · lack of sterility
See all →- SevereK.C. Pharmaceuticals Recalls Dry Eye Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Multiple Brands of Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Assurance Issues
FDA (Drugs) · 2026-09-30
- SevereGentle Eyes Lubricant Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
Similar recalls
- SevereLeiter's Pharmacy Recalls Lidocaine/Phenylephrine Vials Due to Sterility Concerns
FDA (Drugs) · 2013-09-25
- HighLidocaine/Phenylephrine Injectable Solution Recalled for Sterility Defect
FDA (Drugs) · 2022-11-09
- HighCompounded Lidocaine-Phenylephrine Injectable Recalled Due to Sterility Assurance Issues
FDA (Drugs) · 2023-10-25
- SevereUS Compounding Recalls Phenylephrine and Lidocaine Vials Due to Sterility Concerns
FDA (Drugs) · 2015-11-25
- SevereFDA Recalls Lidocaine and Phenylephrine Injection Due to Sterility Concerns
FDA (Drugs) · 2016-10-19
- SevereGreen Valley Drugs Recalls Phenylephrine Injection Due to Sterility Concerns
FDA (Drugs) · 2013-05-22